HANGZHOU, China, Dec. 7, 2021 /PRNewswire/ — Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its acquisition of Cardiovalve Ltd. (Cardiovalve), a pioneering transcatheter mitral and tricuspid valve treatment company on December 7th, 2021. Venus Medtech will acquire 100% equity interest and corresponding equity […]
Other News
Donisi Health Takes Home First Place in the Prestigious Innovations in Cardiovascular Intervention Competition
MedTech Startup Focused on Home Monitoring for Patients with Congestive Heart Failure and Other Chronic Diseases Wins the 2021 ICI Pitch Competition and $200,000 Award TEL AVIV, Israel, Dec. 8, 2021 /PRNewswire/ — Donisi Health (Donisi) prevailed in this year’s ICI Innovation Competition – the premier international conference for innovations in cardiovascular intervention. Competing against […]
Stereotaxis Robotic Technology Reduces Incidence of Silent Cerebral Embolism During Atrial Fibrillation Ablation in New Peer-Reviewed Publication
ST. LOUIS, Dec. 08, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in Frontiers in Cardiovascular Medicine titled “Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism.” This multi-center, prospective study […]
RSIP Vision Presents New Technology for Non-Invasive Planning of Coronary Intervention
Innovative technology provides accurate coronary artery 3D reconstruction from 2D angiography to be used for diagnosis, measurements, stent modelling, and characterization for procedural planning TEL AVIV, Israel & SAN JOSE, Calif.–(BUSINESS WIRE)–RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced AI and computer vision solutions, today […]
Cardiac Insight’s Cardea 20/20 ECG™ System Utilized by the United States Coast Guard Auxiliary in Conjunction With the USCG Academy Medical Clinic to Screen Newly Recruited USCG Academy Cadets for Risk of Sudden Cardiac Death (SCD)
BELLEVUE, Wash.–(BUSINESS WIRE)–Sudden Cardiac Arrest (SCA) is the leading medical cause of death in young athletes during sport. The presence of congenital abnormalities and electrical abnormalities within the heart that cause SCA can be detected by performing a simple, noninvasive 12-lead ‘ECG’ test or electrocardiogram. The United States Coast Guard […]
Artio Medical Announces Development Agreement with the City of Olathe, KS
Company plans construction of a new commercial manufacturing facility Prairie Village, KS – December 8, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that the City Council of Olathe, KS has approved a development agreement […]
Sequana Medical announces positive interim results of SAHARA DESERT, the alfapump DSR® study in heart failure patients with persistent congestion
Interim data from six patients indicate that alfapump DSR therapy can: safely, effectively and rapidly eliminate persistent congestion and restore euvolemia in diuretic-resistant heart failure patients, considerably benefit cardio-renal status, and dramatically improve diuretic responsiveness for months post–treatment Recruitment on–track to report top–line data in H2 2022 Long-term follow-up of RED DESERT patients shows durable improvement in diuretic response following alfapump DSR therapy Proprietary DSR Infusate 2.0 development on track to start MOJAVE […]
Foldax Receives Approval for Clinical Trial of TRIA Biopolymer Surgical Aortic Heart Valve in India
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced that the Drugs Controller General of India (DCGI), India’s regulatory body for medical devices, has approved initiation of a clinical trial of the TRIA™ biopolymer surgical aortic heart valve. The TRIA valve reimagines the heart valve by combining the company’s proprietary biopolymer – […]
CereVasc Announces Publication of First-in-Human Case Report of its eShunt System for the Treatment of Communicating Hydrocephalus
Case represents the first time hydrocephalus has been successfully treated using a minimally-invasive endovascular procedure BOSTON, Dec. 7, 2021 /PRNewswire/ — CereVasc, Inc., a clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, announced today the publication of a case report detailing the first treatment in a study of […]
LiveCare Partners with AliveCor to Launch Enhanced Remote Cardiac Monitoring Solution for Geriatric Patients at Home and in Skilled Nursing Facilities
NEW YORK, Dec. 7, 2021 /PRNewswire/ — LiveCare, a leader in geriatric monitoring technology, today announced the successful integration of AliveCor’s KardiaMobile® 6L, the world’s most clinically-validated personal electrocardiogram (EKG) device, within the LiveCare Link+ smart RPM gateway. Now, patients and their caregivers will receive real-time EKG monitoring at home or in skilled nursing […]



